Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Patients with metastatic cancer had better quality of life, clinical outcomes, and sense of well-being when they regularly ...

University Hospitals will invest $39 million to build a new regional cancer hub at UH TriPoint Medical Center in Concord ...

Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...

Burnout in US oncologists has increased over the past 10 years, according to results of 2 surveys. 1 Researchers compared results of a 2023 survey of 328 oncologists to results of a 2013 survey of ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

In the middle of this list of 10 small-cap stocks insiders are selling recently is Bicycle Therapeutics plc (NASDAQ:BCYC), a ...

Riyadh, Saudi Arabia - His Excellency the Minister of Health of the Kingdom of Saudi Arabia, Mr. Fahd bin Abdulrahman ...

Pyridostigmine bromide extended-release tablets: Alvogen and Rising Pharmaceuticals have both reported shortages of pyridostigmine bromide 180-milligram, extended-release tablets. Rising estimated ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are covering the company, Ratings reports. Three ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...